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Introduction
The mortality of human H5N1 (pneumonia) is very
high. The cumulative number of confirmed human
cases of avian influenza A(H5N1) reported is 504, and
59.3% of them have been dead (situation on 12, August
2010). Early intervention could improve the prognosis of
this disease.
Methods
In order to initiate appropriate treatment earlier, we
perform a three step strategy named “Comprehensive
Therapy for human A (H5N1): CT-H5N1” in northern
Vietnam since 2008. Upon step 1, residents are educated
to visit healthcare facilities sooner when he/she gets sick
after close contact with sick/dead poultry; on Step 2,
medical staffs in provincial hospitals make a diagnosis
using a rapid diagnostic test for A(H5N1) that our col-
leagues developed. If positive, the patient is initiated
antiviral treatments immediately and is referred to Cen-
tral Hospital (BMH), if he/she is in severe condition;
and on Step 3, the patient in critical condition is given
advanced and intensive treatments including blood puri-
fication therapy.
Results
Since December, 2008, we have been able to enroll 3
patients into our collaborative clinical research. All of
them successfully survive.
Conclusion
CT-H5N1 would be effective; however enrollment of
more patients is desirable.
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